387 related articles for article (PubMed ID: 9392429)
1. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
2. Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol.
Bielicki JK; McCall MR; Stoltzfus LJ; Ravandi A; Kuksis A; Rubin EM; Forte TM
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1637-43. PubMed ID: 9327756
[TBL] [Abstract][Full Text] [Related]
3. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
4. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
6. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
Cho KH; Durbin DM; Jonas A
J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
[TBL] [Abstract][Full Text] [Related]
8. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
Calabresi L; Canavesi M; Bernini F; Franceschini G
Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
[TBL] [Abstract][Full Text] [Related]
9. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT.
Forte TM; Bielicki JK; Goth-Goldstein R; Selmek J; McCall MR
J Lipid Res; 1995 Jan; 36(1):148-57. PubMed ID: 7706940
[TBL] [Abstract][Full Text] [Related]
11. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
Francone OL; Royer L; Haghpassand M
J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
[TBL] [Abstract][Full Text] [Related]
13. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
14. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
[TBL] [Abstract][Full Text] [Related]
15. A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis.
Rocco AG; Mollica L; Gianazza E; Calabresi L; Franceschini G; Sirtori CR; Eberini I
Biophys J; 2006 Oct; 91(8):3043-9. PubMed ID: 16891368
[TBL] [Abstract][Full Text] [Related]
16. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
Sparks DL; Frank PG; Neville TA
Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
[TBL] [Abstract][Full Text] [Related]
17. Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity.
Calabresi L; Vecchio G; Frigerio F; Vavassori L; Sirtori CR; Franceschini G
Biochemistry; 1997 Oct; 36(41):12428-33. PubMed ID: 9376346
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
Weidman SW; Ragland JB; Sabesin SM
J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
[TBL] [Abstract][Full Text] [Related]
20. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.
Clay MA; Pyle DH; Rye KA; Barter PJ
J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]